Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Hims & Hers

< Previous 1 2 Next >

Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers

March 26, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

March 10, 2026

From Hims & Hers

Via Business Wire

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

March 10, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Announces Strategic Shift for US Weight Loss Business

March 09, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

February 23, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

February 19, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

February 05, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

February 04, 2026

From Hims & Hers

Via Business Wire

Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

February 02, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over

January 29, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Brings Comprehensive Weight Loss Programme to the UK

December 10, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Continues Major International Expansion With Official Entry Into Canada

December 04, 2025

From Hims & Hers

Via Business Wire

Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology

December 03, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization

November 17, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

November 17, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys

November 13, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

November 03, 2025

From Hims & Hers

Via Business Wire

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026

October 15, 2025

From Hims & Hers

Via Business Wire

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

October 13, 2025

From Hims & Hers

Via Business Wire

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office

October 09, 2025

From Hims & Hers

Via Business Wire

Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

September 10, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results

August 04, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care

July 29, 2025

From Hims & Hers

Via Business Wire

Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025

July 14, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion

July 09, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland

June 03, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Introduces 6-Month Wegovy® New Customer Offer

May 22, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

May 08, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

May 08, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

May 08, 2025

From Hims & Hers

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.